mw drs M.A.E. Nieuwhof, dr H.J.E.M. Janssens Nr 5|2018 (52)|Page 45-46|New
In recent years, post-marketing studies of the new oral blood glucose lowering drugs haven been undertaken. These studies are important to ascertain the long-term cardiovascular efficacy and safety of these drugs, as so far only effects on surr ...
The guideline on ‘Arthritis’ issued by the Dutch College of General Practitioners provides GPs with recommendations for the diagnostic workup and the non-drug and drug treatment of various forms of arthritis. An update was published in 2017.
mw drs M.A.E. Nieuwhof Nr 5|2018 (52)|Page 40-41|New
One disadvantage of direct oral anticoagulants (DOACs) is that their coagulant action cannot be corrected, whereas this is possible with vitamin-K antagonists. The arrival of idarucizumab has made a direct antidote available, although this only ...
mw S. van der Heijden MSc Nr 5|2018 (52)|Page 37-38|New
The study discussed here shows that the use of a mesh significantly reduces the risk of recurrence within two years of small (1–4 cm) umbilical hernias among adults relative to primary suture repair. If 13 patients are treated with mesh instead ...
Pill verdict 'sufficient' means that this medicine has sufficient added value for use in the treatment of the condition.
Pill verdict 'moderate' means that this medicine has moderate added value for use in the treatment of the condition, or that the added value of the medicine can't be assessed yet on the basis of the current research results.
Pill verdict 'insufficient' means that this medicine has insufficient added value for use in the treatment of the condition.